These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27656544)

  • 21. Hodgkin lymphoma as a novel presentation of familial DICER1 syndrome.
    Kuhlen M; Hönscheid A; Schemme J; Merz H; Mauz-Körholz C; Borkhardt A; Troeger A
    Eur J Pediatr; 2016 Apr; 175(4):593-7. PubMed ID: 26526666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathologic and clinical features of 77 Hodgkin's lymphoma patients treated in a lymphoma protocol (LNH87): a GELA study.
    Cazals-Hatem D; André M; Mounier N; Copin MC; Divine M; Berger F; Bosly A; Kerneis Y; Brière J; Quesnel B; Diebold J; Gaulard P
    Am J Surg Pathol; 2001 Mar; 25(3):297-306. PubMed ID: 11224599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Separate diagnoses of Hodgkin lymphoma and non-Hodgkin lymphoma in an individual patient might not signify a common clonal origin.
    Ganzel C; Pogrebijsky G; Krichevsky S; Neuman T; Yehuda DB
    Exp Hematol; 2012 Sep; 40(9):698-704.e2. PubMed ID: 22659385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary cutaneous CD30 positive T-cell lymphoproliferative disorders with aberrant expression of PAX5: report of three cases.
    Hagiwara M; Tomita A; Takata K; Shimoyama Y; Yoshino T; Tomita Y; Nakamura S
    Pathol Int; 2012 Apr; 62(4):264-70. PubMed ID: 22449230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma.
    Peh SC; Kim LH; Poppema S
    Am J Surg Pathol; 2001 Jul; 25(7):925-9. PubMed ID: 11420464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IMP3 as a supplemental diagnostic marker for Hodgkin lymphoma.
    Tang H; Wei Q; Ge J; Jian W; Liu J; Zhong L; Fu B; Zhao T
    Hum Pathol; 2013 Oct; 44(10):2167-72. PubMed ID: 23845468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hodgkin-like posttransplant lymphoproliferative disorder in children: does it differ from posttransplant Hodgkin lymphoma?
    Ranganathan S; Webber S; Ahuja S; Jaffe R
    Pediatr Dev Pathol; 2004; 7(4):348-60. PubMed ID: 14564542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression of CD137 in tumor cells of Hodgkin lymphoma from Northern China and its application in pathological differential diagnosis].
    Shi YF; Gao ZF; Liu CL; Huang X; Song YQ; Zhang C; Lin DM; Zhou LX; Zhao M; Lai YM; Li M
    Zhonghua Xue Ye Xue Za Zhi; 2016 Jun; 37(6):484-90. PubMed ID: 27431073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative flow immunophenotypic features of the inflammatory infiltrates of Hodgkin lymphoma and lymphoid hyperplasia.
    Hudnall SD; Betancourt E; Barnhart E; Patel J
    Cytometry B Clin Cytom; 2008 Jan; 74(1):1-8. PubMed ID: 18061945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hodgkin's lymphoma: immunohistochemical features and its association with EBV LMP-1. Experience from a South Indian hospital.
    Karnik S; Srinivasan B; Nair S
    Pathology; 2003 Jun; 35(3):207-11. PubMed ID: 14506963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discordant lymphoma consisting of mediastinal large B-cell lymphoma and nodular sclerosis Hodgkin lymphoma in the right supraclavicular lymph nodes: a case report.
    Zhang C; Yi Y; Chen C; Wang J; Liu Z
    Diagn Pathol; 2015 Dec; 10():215. PubMed ID: 26715530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ALK-positive anaplastic large cell lymphoma mimicking nodular sclerosis Hodgkin's lymphoma: report of 10 cases.
    Vassallo J; Lamant L; Brugieres L; Gaillard F; Campo E; Brousset P; Delsol G
    Am J Surg Pathol; 2006 Feb; 30(2):223-9. PubMed ID: 16434897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cigarette smoking and risk of lymphoma in adults: a comprehensive meta-analysis on Hodgkin and non-Hodgkin disease.
    Sergentanis TN; Kanavidis P; Michelakos T; Petridou ET
    Eur J Cancer Prev; 2013 Mar; 22(2):131-50. PubMed ID: 22759975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Borderline between Hodgkin and non-Hodgkin lymphomas with unfavorable clinical course: a clinical, histological and immunohistochemical analysis of 33 cases within the German Hodgkin Lymphoma Study].
    Bernhards J; Fischer R; Werner M; Hübner K; Schwarze EW; Georgii A
    Verh Dtsch Ges Pathol; 1992; 76():159-63. PubMed ID: 1283250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Composite lymphoma of peripheral T-cell lymphoma and Hodgkin lymphoma, mixed cellularity type; pathological and molecular analysis.
    Ichikawa A; Miyoshi H; Yamauchi T; Arakawa F; Kawano R; Muta H; Sugita Y; Akashi K; Ohshima K
    Pathol Int; 2017 Apr; 67(4):194-201. PubMed ID: 28191697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrafollicular classical Hodgkin lymphoma mimicking nodular lymphocyte predominant Hodgkin lymphoma: a report of two cases.
    Tatsuno M; Maeshima AM; Kim SW; Maruyama D; Taniguchi H; Miyamoto K; Fukuhara S; Kobayashi Y; Tobinai K; Kushima R
    Pathol Int; 2014 Dec; 64(12):613-7. PubMed ID: 25394195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of lymphoid lesions of the head and neck using combined fine needle aspiration cytology and flow cytometry: Accuracy and pitfalls.
    Crous H; Gillam A; Kalokerinos MA; Knezevic S; Hobson P; Papadimos DJ; Shield PW
    Cytopathology; 2019 Jul; 30(4):370-377. PubMed ID: 30985042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new approach to the study of Hodgkin lymphoma by flow cytometry.
    Beatriz Álvarez Flores M; Sopeña Corvinos M; Medrano Élez M; Soto Del Pecho B; Conejo Sánchez L; García de la Fe J; Guillén Santos R; Cava Valenciano F
    Pathology; 2023 Feb; 55(1):86-93. PubMed ID: 36137774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical assessment of the diagnostic utility of PD-L1: a preliminary analysis of anti-PD-L1 antibody (SP142) for lymphoproliferative diseases with tumour and non-malignant Hodgkin-Reed-Sternberg (HRS)-like cells.
    Sakakibara A; Kohno K; Eladl AE; Klaisuwan T; Ishikawa E; Suzuki Y; Shimada S; Nakaguro M; Shimoyama Y; Takahara T; Kato S; Asano N; Nakamura S; Satou A
    Histopathology; 2018 Jun; 72(7):1156-1163. PubMed ID: 29380399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spectrum of malignant lymphomas in Klang Hospital, a public hospital in Malaysia.
    Peh SC; Kim LH; Thanaletchimy N; Chai SP; Poppema S
    Malays J Pathol; 2000 Jun; 22(1):13-20. PubMed ID: 16329532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.